Combination Has Synergistic Effect Against Human Colon Cancer Cell Lines

April 23, 2007 – 6:03 pm | posted in Colorectal Cancer

Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced that a poster by Dr. Maureen E. Lane et al. of Cornell University, New York, entitled "In Vivo Synergy between Oncolytic Reovirus and Gemcitabine in Ras-Mutated Human HCT116 Xenografts" was presented at the American Association for Cancer Research (AACR) Annual Meeting in Los Angeles, CA.

The researchers found that treatment of human colon cancer cell lines with the combination of REOLYSIN® and gemcitabine resulted in both in vitro and in vivo synergy. There was no toxicity associated with the combined treatment. Tumours treated with the combination were significantly smaller (by area and weight) than tumours in control groups or tumours treated with either agent alone. The researchers concluded that the synergistic combination of REOLYSIN® and gemcitabine is a promising therapeutic regimen for study in clinical trials.

"It is rare to see the virtual elimination of tumours as well as the long-lasting therapeutic effect that we have observed from this study," said Dr. Brad Thompson, President and CEO of Oncolytics. "We are very encouraged by these results and look forward to testing this particular treatment combination in our upcoming human systemic administration trial in the U.K."

ShareThis

Also Read

  • Celator(R) Pharmaceuticals Study Shows CPX-571 Maintains Synergistic Ratio Of Irinotecan And Cisplatin To Improve Anti-tumor Activity
  • Chemotherapy Can Be More Toxic To Brain Cells Than To Cancer Cells And May Cause Brain Damage
  • Cell Death In Leukemia Induced By Massey Researchers
  • New Research Identifies Human Enzyme That Could Be Programmed To Kill Cancer Cells
  • New Chemotherapy Agent Provides Synergistic Effect To Standard Drugs
  • Biothera Drug Synergistic With Avastin(R) Against Cancer, Study Finds
  • Stem Cells May Trigger Tumors
  • Colonoscopy Remains The Most Effective Screening Option For Colon Cancer
  • Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
  • Action Of Cancer Cells Holds Potential For Cancer Treatment

    • You must be logged in to post a comment.